Guangzhou Baiyunshan Pharmaceutical Holdings Company (0874) Price & Analysis

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H lowest stock price was HK$15.76 and its highest was HK$19.54 in the past 12 months.

What is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s market cap?

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s market cap is $43.00B.

When is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s upcoming earnings report date?

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s upcoming earnings report date is Oct 28, 2025 which is in 8 days.

How were Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s earnings last quarter?

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H released its earnings results on Aug 16, 2025. The company reported HK$1.687 earnings per share for the quarter, beating the consensus estimate of N/A by HK$1.687.

Is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H overvalued?

According to Wall Street analysts Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H pay dividends?

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H pays a Quarterly dividend of HK$0.44 which represents an annual dividend yield of 7.38%. See more information on Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H dividends here

What is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s EPS estimate?

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H have?

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H has 219,900,000 shares outstanding.

What happened to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s price movement after its last earnings report?

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H reported an EPS of HK$1.687 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.783%.

Which hedge fund is a major shareholder of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H?

Currently, no hedge funds are holding shares in HK:0874

Guangzhou Baiyunshan Pharmaceutical Holdings Company Stock Smart Score

Neutral

Fundamentals

Return on Equity

7.53%

Trailing 12-Months

Asset Growth

7.19%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874) is a prominent pharmaceutical enterprise based in China, primarily engaged in the research, development, manufacturing, and distribution of a wide range of pharmaceutical products. The company operates in several sectors, including traditional Chinese medicine, chemical pharmaceuticals, and health products. Its core offerings encompass prescription drugs, over-the-counter medications, and various health supplements, catering to both domestic and international markets.